More stories
Mitchell’s Plan to Address Michigan SB1 No-Fault Legislation for Bill Review
Mitchell has developed a four-step plan to address Michigan SB1 for bill review applications.
Virtual Connections: Utilizing Technology to Build and Deepen Relationships with Injured Workers
As the telemedicine industry continues to boom we’re seeing more and more new forms of telehealth emerge in the marketplace. Variations including tele-rehab, remote patient monitoring and even “avatar-like” nurses being utilized by hospital systems and providers. In this new world of telehealth we need to constantly be looking for innovative modes by which triage and telephonic case managers can connect with the individuals they serve and engage them on their road to recovery. At Coventry we are piloting two new types of Virtual Connections designed to support our clinical staff in the establishment of trust and engagement with injured workers – Virtual Triage and Video-Telephonic Case Management.
FDA Approves Generic Lyrica Pregabalin
One of the most talked-about drug patents in workers' compensation, Pfizer's Lyrica (pregabalin), patent extensions ended on July 1, 2019.
Mitchell Announces Partnership with Drew Technologies to Deliver OEM Scanning and Remote Diagnostic Support
Enhancements from Drew extend Mitchell Diagnostics' (MD) industry-leading product suite capabilities for collision repairers with new MD-OEM option.
StateWatch: Bill Review July 2019
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
Understanding Brand & Generic Utilization and Cost
In 2018, First Script realized a 0.6% increase in generic utilization.1 Generic medications contain the same active ingredient and approved indications as their brand name counterparts. An increase of 0.6% might not seem like a lot; however, when the difference in cost per script is considered, it is easy to see why a shift in favor of generic use is a win and can be a big cost saver.